|
|
Substance Name: Afloqualone [INN:JAN]
RN: 56287-74-2
UNII: CO4U2C8ORZ
InChIKey: VDOSWXIDETXFET-UHFFFAOYSA-N
Classification Codes
- Central Nervous System Agents
- Dermatologic Agents
- Drug / Therapeutic Agent
- Muscle Relaxants, Central
- Neuromuscular Agents
- Peripheral Nervous System Agents
- Photosensitizing Agents
- Radiation-Sensitizing Agents
Molecular Formula
- C16-H14-F-N3-O
Molecular Weight
- 283.305
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Afloqualone
- Afloqualone [INN:JAN]
Synonyms
- 5-25-15-00102 (Beilstein Handbook Reference)
- 6-Amino-2-(fluoromethyl)-3-o-tolyl-4(3H)-chinazolinon
- 6-Amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone
- 6-Amino-3,4-dihydro-2-fluoromethyl-3-(2-methylphenyl)-4-chinazolinon
- Afloqualon
- Afloqualona
- Afloqualona [INN-Spanish]
- Afloqualone
- Afloqualonum
- Afloqualonum [INN-Latin]
- Aroft
- Arofuto
- BRN 0819769
- HQ 495
- UNII-CO4U2C8ORZ
Systematic Names
- 4(3H)-Quinazolinone, 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-
- 4(3H)-Quinazolinone, 6-amino-2-fluoromethyl-3-(o-tolyl)-
- 6-Amino-2-(fluoromethyl)-3-o-tolyl-4(3H)-quinazolinone
Registry Numbers
CAS Registry Number
- 56287-74-2
FDA UNII
- CO4U2C8ORZ
System Generated Number
- 0056287742
Structure Descriptors
InChI
InChI=1S/C16H14FN3O/c1-10-4-2-3-5-14(10)20-15(9-17)19-13-7-6-11(18)8-12(13)16(20)21/h2-8H,9,18H2,1H3InChIKey
VDOSWXIDETXFET-UHFFFAOYSA-NSmiles
Cc1ccccc1N2C(=Nc3ccc(N)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 272mg/kg (272mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 991, 1983. |
mouse | LD50 | oral | 397mg/kg (397mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 991, 1983. |
mouse | LD50 | subcutaneous | 591mg/kg (591mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 991, 1983. |
rat | LD50 | intraperitoneal | 385mg/kg (385mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 991, 1983. |
rat | LD50 | oral | 249mg/kg (249mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 991, 1983. |
rat | LD50 | subcutaneous | 823mg/kg (823mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 991, 1983. |